AstraZeneca says U.S. trial shows its Covid vaccine is 79 percent effective

With 32,000 participants in its U.S. trial, AstraZeneca says its vaccine was 79 percent effective in preventing Covid-related illnesses and 100 percent effective in preventing hospitalizations and deaths.